160 related articles for article (PubMed ID: 29857113)
1. High dose targeted delivery on cancer sites and the importance of short-chain fatty acids for metformin's action: Two crucial aspects of the wonder drug.
Maniar K; Singh V; Chakrabarti A; Bhattacharyya R; Banerjee D
Regul Toxicol Pharmacol; 2018 Aug; 97():15-16. PubMed ID: 29857113
[TBL] [Abstract][Full Text] [Related]
2. Metformin exerts anti-obesity effect via gut microbiome modulation in prediabetics: A hypothesis.
Maniar K; Moideen A; Bhattacharyya R; Banerjee D
Med Hypotheses; 2017 Jul; 104():117-120. PubMed ID: 28673568
[TBL] [Abstract][Full Text] [Related]
3. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
4. A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug?
Maniar K; Moideen A; Mittal A; Patil A; Chakrabarti A; Banerjee D
Pharmacol Res; 2017 Mar; 117():103-128. PubMed ID: 27939359
[TBL] [Abstract][Full Text] [Related]
5. Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?
Christodoulou MI; Scorilas A
Curr Med Chem; 2017; 24(1):14-56. PubMed ID: 27604091
[TBL] [Abstract][Full Text] [Related]
6. Metformin: old friend, new ways of action-implication of the gut microbiome?
Rodriguez J; Hiel S; Delzenne NM
Curr Opin Clin Nutr Metab Care; 2018 Jul; 21(4):294-301. PubMed ID: 29634493
[TBL] [Abstract][Full Text] [Related]
7. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
8. The Gut Microbiome, Metformin, and Aging.
Induri SNR; Kansara P; Thomas SC; Xu F; Saxena D; Li X
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():85-108. PubMed ID: 34449247
[TBL] [Abstract][Full Text] [Related]
9. Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
Bahne E; Hansen M; Brønden A; Sonne DP; Vilsbøll T; Knop FK
Diabetes Obes Metab; 2016 Oct; 18(10):955-61. PubMed ID: 27265206
[TBL] [Abstract][Full Text] [Related]
10. Metformin - its potential anti-cancer and anti-aging effects.
Podhorecka M; Ibanez B; Dmoszyńska A
Postepy Hig Med Dosw (Online); 2017 Mar; 71(0):170-175. PubMed ID: 28258677
[TBL] [Abstract][Full Text] [Related]
11. [Metformin's effect on 5-fluorouracil,cisplatin,paclitaxel in laryngocarcinoma Hep-2 cells].
Zhou CY; Li XM; Shan S; Jia LF; Huang ZL
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):524-528. PubMed ID: 29871302
[No Abstract] [Full Text] [Related]
12. Crucial microRNAs and genes in metformin's anti-pancreatic cancer effect explored by microRNA-mRNA integrated analysis.
Li Y; Li L; Zhang G; Wang Y; Chen H; Kong R; Pan S; Sun B
Invest New Drugs; 2018 Feb; 36(1):20-27. PubMed ID: 28875433
[TBL] [Abstract][Full Text] [Related]
13. Current understanding of metformin effect on the control of hyperglycemia in diabetes.
An H; He L
J Endocrinol; 2016 Mar; 228(3):R97-106. PubMed ID: 26743209
[TBL] [Abstract][Full Text] [Related]
14. [Metformin is a possible glucagon-like peptide 1 stimulator].
Bahne E; Brønden A; Vilsbøll T; Knop FK
Ugeskr Laeger; 2018 Mar; 180(12):. PubMed ID: 29559078
[TBL] [Abstract][Full Text] [Related]
15. Metformin and the Gut Microbiome in Diabetes.
Devaraj S; Venkatachalam A; Chen X
Clin Chem; 2016 Dec; 62(12):1554-1555. PubMed ID: 27650682
[No Abstract] [Full Text] [Related]
16. Metformin and gut microbiota: their interactions and their impact on diabetes.
Vallianou NG; Stratigou T; Tsagarakis S
Hormones (Athens); 2019 Jun; 18(2):141-144. PubMed ID: 30719628
[TBL] [Abstract][Full Text] [Related]
17. Metformin: Insights into its anticancer potential with special reference to AMPK dependent and independent pathways.
Ikhlas S; Ahmad M
Life Sci; 2017 Sep; 185():53-62. PubMed ID: 28755883
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of metformin action: In and out of the gut.
Minamii T; Nogami M; Ogawa W
J Diabetes Investig; 2018 Jul; 9(4):701-703. PubMed ID: 29777629
[TBL] [Abstract][Full Text] [Related]
19. Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review.
Ahmed ZSO; Golovoy M; Abdullah Y; Ahmed RSI; Dou QP
Recent Pat Anticancer Drug Discov; 2021; 16(2):161-186. PubMed ID: 34132186
[TBL] [Abstract][Full Text] [Related]
20. Metformin, aging and cancer.
Moiseeva O; Deschênes-Simard X; Pollak M; Ferbeyre G
Aging (Albany NY); 2013 May; 5(5):330-1. PubMed ID: 23660016
[No Abstract] [Full Text] [Related]
[Next] [New Search]
